Xcout Intel
Cellestial Health competitors & alternatives
The 12 closest competitors and alternatives to Cellestial Health among healthcare companies — ranked by similarity to what Cellestial Health actually does, not by market-cap band.
Subscribe to see Cellestial Health’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Cellestial Health
Cellestial Health is a privately held therapeutics development company spun out from the University of Cambridge in 2023 to create new treatments for Parkinson's disease and related conditions.
Cellestial Health at a glance
Cellestial Health is a healthcare company headquartered in United Kingdom, founded in 2023. Its most recent funding round, Pre-Seed, raised $654,000 in May 2025. Xcout tracks 1 named person at Cellestial Health, including Nat Hastings (CEO).
Cellestial Health leadership
- Nat HastingsCEO
Cellestial Health funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $654,000 | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Cellestial Health competitors
Ranked by semantic similarity — how close each company is to Cellestial Health by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthcare company
Neusignal Therapeutics, Inc. is a Tokyo-based company focused on commercializing early-stage drug discovery from Tohoku with the goal of defeating dementia.
Similar healthcare company
Headquartered in Clermont-Ferrand, France, Axoltis Pharma is a biotechnology company focused on developing novel therapeutic solutions to restore blood-brain barrier integrity and treat neurodegenerative diseases.
Similar healthcare company
CardiaTec Biosciences is a biotechnology research company headquartered in Cambridge, United Kingdom, focused on AI-driven cardiovascular discovery.
Health Care
Herantis Pharma Oyj is a clinical-stage biotechnology company that develops disease-modifying therapies to halt or reverse the progression of neurodegenerative diseases. The company focuses on researching and advancing innovative treatments, such as its lead drug candidate HER-096, to address significant unmet medical needs.
Similar healthcare company
Full Circles Therapeutics Inc. is a biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on therapeutic innovations and engages in in vivo cell research collaborations.
Similar healthcare company
Argobio is a startup studio located in Paris, France, dedicated to biotechnology and novel therapeutics. The organization operates at the intersection of academia and venture capital to transform scientific discoveries into de-risked pharmaceutical companies.
Similar healthcare company
Monument Therapeutics is a neuroscience-focused precision and stratified medicine company applying digital biomarkers to psychiatric drug development. It develops novel treatments, such as MT1988, for central nervous system disorders. Headquartered in Manchester, the company combines digital tools with clinical research to advance breakthrough therapeutics.
Similar healthcare company
Healome Therapeutics is an eye care therapeutics company headquartered in Birmingham, United Kingdom. The company focuses on developing more effective, safer, and practical treatments for vision-threatening ocular surface diseases.
Similar healthcare company
SolasCure Limited is a biotechnology research company registered and headquartered in Cambridge, United Kingdom, focused on developing novel wound care solutions.
Biotech
Cellular Intelligence is a biotechnology company that develops engineered cell therapies, including the acquisition of a Phase 2-ready cell therapy for Parkinson's disease. The company applies cell fate engineering to advance treatments for patients.
Biotechnology
Harness Therapeutics Ltd. is a biotechnology company founded in 2023 and based in Cambridge, United Kingdom. The company focuses on RNA biology and the development of novel therapeutics for the treatment of neurodegenerative diseases.
Biotechnology
Crucible Therapeutics is a biopharmaceutical company founded in 2023 to develop novel therapies for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, originating from research at the Sheffield Institute for Translational Neuroscience.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Cellestial Health and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Cellestial Healthand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →